New Concepts in Transitioning: Medical, Psychosocial ...

New Concepts in Transitioning: Medical, Psychosocial ...

Chicago Experience, Progress, Outcomes, and Expectations for the Future Shonda King, MSW, LSW Medical Social Consultant University of Illinois Medical Center Comprehensive Sickle Cell Center Presenter Disclosures Shonda King No relationships to disclose

Purpose The purpose of my presentation is to provide an overview of the panel presentations and briefly discuss the significance that Chicago, specifically the University of Illinois at Chicago, has played in the advancement of care for those affected by Sickle Cell Disease. Presentation Outline Experience: Chicago Connection to Sickle Cell Disease Progress and Contributions Outcomes: Comprehensive Care at All Life Stages Future: Transitioning, Group Education, and Cure

Experience Disease was discovered here at Rush University Medical Center in 1910 University of Illinois at Chicago became home to one of the NIHs first ten nationwide elite Comprehensive Sickle Cell Centers in 1972. The national organization for Sickle Cell Support was founded here in 1971 under the name the Midwest Association for Sickle Cell Anemia (MASCA), it is now called the Sickle Cell Disease Association of America. U of I Physicians and Researchers have contributed significantly to the advancement of care for individuals with sickle cell disease since the 70s

Progress and Contributions Epigetic Gene Therapy (Dr. Joseph DeSimone, Dr. Rivers) Prophylactic Penicillin [PROPS Study] Hydroxyurea (Dr. Mabel Koshy) Sickle Eye Disease (Dr. Maurace Rabb) Pregnancy and Sickle Disease (Dr. Mabel Koshy) Baby HUGS [Pediatric Hydroxyurea Study] Kidney Disease (Dr. Santosh Saraf) Psychosocial Needs (Dr. Anita Hurtig) Metabolism of Opiates (Dr. Robert Molokie, Dr. S. Shord) Acute Care Treatment Center (Dr. Michel Gowhari) Stem Cell Transplantation (Dr. Santosh Saraf)

Hemoglobin F Inducers (Dr. Rivers, Dr. Lavelle) Outcomes: Dr. Joseph DeSimone and Epigenetics Thanks to U of I Geneticist Dr. Joseph DeSimone et. al, 5azacytadine was the first epigenetic study in the United States and sickle cell disease was used as the first model for treatment in diseases.1,2 The drug has epigenetic effects on RNA and DNA and was used to increase fetal hemoglobin to reduce the incidence of pain crisis and the duration of painful crisis. Cancer therapies are designed better because of this study . 1. 2.

Heller, P. and DeSimone, J. (1984). 5-azacytidine and fetal hemoglobin. American Journal of Hematology, 17(4), 439-447. Saunthararajah, Y. et al (2003). Effects of 5-aza-2-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. Blood, 102(12). Outcomes: Dr. Mabel Koshey and Hydroxyurea 1 UIC enrolled the largest number of patients to participate in the Double Blinded study. Results showed that Hydroxyurea was effective in decreasing painful crisis and hospitalizations No direct correlations of QOL with the study, but personal patient testimonies document the research participants

satisfaction. Hydroxyurea approved by the FDA in 1991 as an effective drug to manage SCD. 1. Charache, S. (1995). Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. New England Journal of Medicine, 332(20): 1317-22. Outcomes: Eye Disease and Pregnancy Protocols on Sickle Eye Disease [Retinal Detachments, Strokes in the Eye, and Floaters] came from the work of Ophthalmologist Dr. Maurace Rabb who was a Professor

and Clinician in the UIC Ear and Eye Infirmary.1 Recommendations on the care of pregnant females with sickle cell disease came from former UIC Director Dr. Mable Koshy.2,3 1. Apple, D.J. and Rabb, M., 1978. Clinicopathologic correlation of ocular disease: a text and stereoscopic atlas. C.V. Mosby: St. Louis. 2. Koshy, M and Byrd, L. (1991). Management of pregnancy and sickle cell syndromes. Hematology/Oncology Clinics of North America, 5(3), 585-596. 3. Rogers, D. and Molokie, R.E. (2011). Sickle Cell Disease in Pregnancy. Obstetrics and Gynecology Clinic in North America. 37(2), 223-37. Outcomes: Psychosocial Progress UIC Pediatric Psychologist Dr. Anita Hurtig1 looked at the QOL of

pediatric patients with SCD and recommended that those patients receive NP assessments to determine their cognitive level of functioning and made recommendations on now to structure services to increase this level of functioning. In 2004, Shonda King, MSW, LSW developed the concept categories of comprehensive transitional care for young adults with sickle cell disease. 1. Hurtig, A.L. and Viera, C.T., (1986). Sickle cell disease : psychological and psychosocial issues. University o Illinois Press: Urbana, Illinois.

Outcomes: Metabolism of Opiates Research conducted by Hematologist/Oncologist Dr. Robert Molokie and Pharmacist Dr. Stacy Shord revealed that because of genetic differences, some groups metabolize Codeine to Morphine differently than others. Individuals with sickle cell disease of West African descent were found to not have the enzyme to metabolize Codeine to Morphine. They metabolize the drug at 50% of its clinical effectiveness compared to other ethnic groups.1 This is significant because those patients who were found with this enzyme deficiency had more frequent ER visits due to their need for higher doses of medication to control their pain

and were not drug seeking. 1. Shord, S. and Molokie, R.E. (2009). The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease. European journal of clinical pharmacology, 65(7), 651-658 Future: Transitioning Transitioning is the process where a pediatric patient transfers from pediatric care to adult centered care. Teenage patients are seen in the Adult Center to initiate the transition. Five areas of Transitioning were identified. Medical

Social and Psychosocial Resource Education Vocation and Career Future: Group Health Education Centering Sickle Disease: Proof of Concept Pilot1 Exclusive to the University of Illinois Hospital and Health Sciences System Comprehensive Sickle Cell Center Have A Heart for Sickle Cell Anemia Foundation2 Unique pediatric and parent support group held at the University of Illinois Hospital and Health Sciences

System. 1. 2. Patil, C.L, Ciribassi, R.M, and King, S. (2014). Centering sickle cell disease: Proof of concept pilot. www.hhsca.org Future: Epigenetics Dr. Angela Rivers1 and Dr. Donald Lavelle1,2 of the University of Illinois Comprehensive Sickle Cell Center are expanding on the work of Dr. Joseph DeSimone and are looking at other ways of stopping the switching of Hemoglobin F to Hemoglobin S in individuals with sickle

cell disease which occurs at about 6 months of age in infants. 1. 2. Rivers et al. (2015). RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases -globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model. Experimental Hematology, 43(7):546-5. Jessie Brown Veterans Administration, Chicago, Illinois Future: Stem Cell Transplants Physicians

at the University of Illinois Hospital & Health Sciences System have cured 12 adult patients of sickle cell disease using a unique procedure for stem cell transplantation from healthy, tissue-matched siblings.1, 2 1. 2. Saraf, S. et al (2015). Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease. Biology of Blood and Marrow Transplantation. http://www.sciencedaily.com/releases/2012/06/120618194714.htm. Chicago woman cured of sickle cell

disease. Conclusion Since the first description of the disease in 1910, Chicago has been a leader in research in the care of patient with sickle cell disease with the University of Illinois playing a significant role in the advancement of care. As new therapies and models of care are being developed, the University of Illinois Hospital and Health Sciences Systems will continue to lead in providing the best in comprehensive care for pediatric and adult patients living with sickle cell disease. Faces of Sickle Cell Disease

Greece Turkey Palestine/ Israel Village in northern Greece where 18% have the sickle cell trait. Both parents have the trait and both children have SS disease. Three sisters from a Bedouin family from Northern Israel. The lady (left) and the 3 children in front all have SCD

A family from Adana in south east Turkey. Both parents and daughter on the left has SCD Faces and Places Shonda King, MSW, LSW Medical Social Consultant Sickle Cell Center Social Worker University of Illinois Hospital and Health Sciences System 840 S. Wood Street (MC 712) Chicago, Illinois 60612

312-996-1785 [email protected]

Recently Viewed Presentations

  • JMF Media Processing Model - csuohio.edu

    JMF Media Processing Model - csuohio.edu

    The Java Media Framework (JMF) is an application programming interface (API) for incorporating time-based media into Java applications and applets The JMF 1.0 API (the Java Media Player API) enabled programmers to develop Java programs that presented time-based media JMF...
  • Chapter 12 History of Life on earth - Nectur

    Chapter 12 History of Life on earth - Nectur

    Reevaluating the Miller-Urey Model. Reactants found in the apparatus have not been proven to be in abundance in the early life of Earth making it hard to create large amounts of organic molecules.. The . lack of an ozone layer...
  • Marine Reserves - INFOFISH

    Marine Reserves - INFOFISH

    Marine fisheries management: Marine fisheries Ordinance and Rules 1983. License for trawler. All trawlers should have fishing license. No foreign fishing vessels can fish in Bangladesh EEZ
  • Biochemistry 455 - University Of Illinois

    Biochemistry 455 - University Of Illinois

    "Things I learned in BIOC 455 will most definitely help me when I enter the workforce." Techniques in Biochemistry & Biotechnology : BIOC 455 BIOC 455: Course Content Dipeptide analysis (2 lab periods) Determination of the amino acid sequence of...
  • صلاحیت های بالینی - آسکی

    صلاحیت های بالینی - آسکی

    Expanding our toolbox….. Knows Knows how Does Knows how Shows how Established technology of structured high fidelity in vitro simulations requiring behavioural performance (OSCE, SP-based testing, OSPE….) Expanding our toolbox…..
  • What is Artificial Intelligence?

    What is Artificial Intelligence?

    University of California, Irvine Other titles: Arial Times New Roman Wingdings Courier New Monotype Corsiva Echo Document Bitmap Image Intorduction to Artificial Intelligence Robotic links CS171 Course overview Course Outline Today's class What is Artificial Intelligence (John McCarthy , Basic...
  • SELF-AUDIT - Louisiana

    SELF-AUDIT - Louisiana

    REVISED LOSS PREVENTION MANUAL & AUDIT 2007 V-1.0 KEY DATES 2/1/08 - ORM Web Site Updated Word version of new manual & self-audit FAQ's (w/periodic updates) Comments/suggestions link (preferred method) 7/1/08 - Compliance Reviews, using old/current self-audit, on activities of...
  • Conference 2011 - Comprehensive School Health

    Conference 2011 - Comprehensive School Health

    by Beth Sanchez * * Today's Objectives Inform you of all the free resources available to you Provide you with ideas of how to promote nutrition in your classrooms, schools and community * Agenda Personal Background OPHEA Teaching nutrition and...